August 2016

    Verily Life Sciences – formerly known as Google Life Sciences – has partnered with Johnson & Johnson medical devices subsidiary Ethicon to form Verb Surgical Inc. The new company “aims to develop a comprehensive surgical solutions platform that will incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals”.

    Verily CEO Andrew Conrad told WIRED.com that although Verb Surgical represented the Alphabet subsidiary’s first partnership, it won’t be the last. “We expect to work closely with pharma, biotech, medical device and diagnostic companies, patient advocacy groups, and academic researchers in different ways for a long time to come,” he said.

    While it’s not entirely clear what Verb Surgical will be developing, there’s some suggestion that the focus will be on robot-assisted technologies to be controlled by human doctors for delicate surgical procedures.

    Robot-assisted surgery is currently at the cutting edge of technical development into both autonomous and assistive devices for tasks such as replacing traditional surgical tools and human hands to hold them in position for extended periods, allowing expert surgeons to work remotely via telemanipulation, or giving doctors fine control over minimally-invasive machine-assisted procedures.

    Gary Pruden, worldwide chairman of Johnson & Johnson Medical Devices said the Ethicon team, which will be developing surgical instruments for Verb’s robotics-assisted platform, “has already made meaningful progress on the robotics platform, which is being developed for application across a host of surgical specialties”.

    Google Life Sciences was officially renamed Verily earlier this week. The company’s previous projects have included glucose-checking contact lenses, disease-detecting nanoparticles and The Baseline Study, which seeks to build a genetic profile of a perfectly healthy human.


    No comments

    Be the first one to leave a comment.

    Post a Comment



    Latest Posts

    Latest Video



    First FDA Approval For Clinical Cloud-Based Deep Learning In Healthcare

     SOURCE: FORBES The first FDA approval for a machine learning application to be used in a clinical setting is a…

    FDA-approved study uses adipose stem cells for treatment of shoulder injuries

    SOURCE Sanford Health is conducting the first clinical trial approved by the FDA to treat injured shoulders using patients’ adipose…

    Could Anatomics BioModel Stereotaxy replace navigation or a robot?

    SOURCE Paul S D’Urso Neurosurgeon & Founder of Anatomics Because 3D printing is so accurate I was able to locate…

    $250 million awarded to new Advanced Robotics Manufacturing Innovation Hub

    SOURCE Headquartered in Pittsburgh, PA, the new institute is made up of governments, industry, academia, and non-profit organizations from across the country….

    Self-assembling 3D printing inks produce more true-to-life tissue

    SOURCE Biological and chemical researchers are developing 3D printable inks capable of self-assembly, i.e. forming a shape based on a…

    Urine Exosomes – An Emerging Trove of Biomarkers

     SOURCE Exosomes are released by most cells and can be isolated from all biofluids including urine. Exosomes are small vesicles…

    What is machine learning?

    SOURCE In this fascinating animation from Oxford Sparks, we take a look at how statistics and computer science can be used to…

    Catalia Health uses social robots to improve health outcomes

    Credit: Catalia Health SOURCE Catalia Health is leading the surge in social robotics, with Mabu, their patient care management system. Catalia…